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ABSTRACT
....................................................................................................................................................
Objective This study assessed whether having an electronic health record (EHR) super-user, nurse champion for meaningful use (MU), and quality
improvement (QI) team leading MU implementation is positively associated with MU Stage 1 demonstration.
Methods Data on MU demonstration of 596 providers in 37 ambulatory care clinics came from the clinical data warehouse and administrative sys-
tems of UNC Health Care. We surveyed the 37 clinics about champions, super-users, and QI teams. We used generalized estimating equation
methods with an independence working correlation matrix to account for clustering within clinics and to weight contributions from each clinic ac-
cording to clinic size.
Results Having a QI team lead MU implementation was significantly associated with MU demonstration (odds ratio, OR¼ 3.57, 95% CI, 1.83-
6.96, P< .001, Table 2). Having neither a nurse champion nor an EHR super-user was significant.
Conclusion Our findings support the alignment of MU with QI efforts by having the QI team lead MU implementation.
....................................................................................................................................................
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BACKGROUND
The Health Information Technology for Economic and Clinical Health
(HITECH) Act provided an unprecedented investment in health IT,1 in-
cluding financial incentives through the Centers for Medicare and
Medicaid Services (CMS) for providers and hospitals that demonstrate
meaningful use (MU) objectives for electronic health records (EHRs).
MU objectives are being implemented in 3 stages,2 with the goal being
to capitalize on the potential of EHRs to facilitate improvements in
safety, quality, and efficiency of care.1,3,4 Although evidence to date is
mixed regarding such improvements,3,5–8 preliminary studies suggest
that demonstrating MU objectives may contribute to improving health
care quality more than simply adopting EHRs.9,10
While studies have analyzed hospital characteristics associated
with EHR adoption and successful MU implementation,11,12 little is
known about approaches used within ambulatory practice settings
that contribute to variations in MU demonstration between settings
within the same integrated delivery system. Findings from 1 qualitative
study suggest that if practices focus on individual tasks required by
MU objectives (eg, documentation requirements) without adequate
support for providers and integration of MU with quality improvement
(QI) initiatives, the sustainability of MU may be jeopardized.13
Integration of MU and QI also is supported by a systematic review that
highlights how IT has promoted QI through improved guideline adher-
ence, enhanced disease surveillance, and reduced medication er-
rors.14 Finally, there is some evidence that quality gains can be driven
by EHR champions who have an interest in QI and process redesign.15
Our study aimed to build on these findings by assessing whether
particular approaches to supporting MU implementation are associated
with successful MU Stage 1 demonstration, specifically having a QI
team that leads MU implementation, an EHR super-user, or an MU
nurse champion. Due to the growing emphasis on quality, as evi-
denced by Accountable Care Organizations and other initiatives, many
health care organizations have established internal teams to oversee
QI-related work. QI teams are often charged with identifying priorities
for improving clinical performance as well as implementing and evalu-
ating changes aimed at improving performance. A QI team, therefore,
is well positioned to create alignment between MU and the identified
priority areas within the practice setting. Furthermore, health care or-
ganizations commonly employ champions and super-users to engage
and support their peers during health IT–related changes, such as MU.
A small body of evidence suggests that these champions/super-users
are key players in successful health IT implementation.16–19
Based on these findings, we expected that practice settings with
QI teams leading MU implementation, those with EHR super-users,
and those with MU nurse champions would have higher percentages
of providers successfully demonstrating MU as compared to settings
that did not employ these approaches. Our study is particularly rele-
vant to ambulatory practices attempting to meet the increasingly chal-
lenging requirements of MU Stages 2 and 3, especially as services
from regional extension centers may no longer be available to support
such efforts. Our findings may suggest internal strategies that support
MU effectively and therefore warrant financial investment.
OBJECTIVE
The purpose of this study was to assess whether having a QI team lead-
ing MU implementation, an EHR super-user, or a nurse champion for MU
is positively associated with successful MU Stage 1 demonstration.
METHODS
Sample, Data Sources, and Measures
In February 2013, we administered a survey to medical directors,
nurse managers, and practice managers in 47 ambulatory care clinics
on the main campus of the UNC Health Care System (UNC HCS). We
received complete responses from 37 clinics (response rate 79%). For
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each clinic, we obtained the numbers of total eligible providers and
those demonstrating MU as of December 2012, which was the end of
year 1 of MU Stage 1. These data were available via a dashboard that
drew from the UNC HCS clinical data warehouse and administrative
systems. Table 1 summarizes the study sample.
The dependent variable for our study was the percentage of eligi-
ble providers in each clinic demonstrating all Stage 1 MU objectives in
December 2012. Stage 1 MU objectives included 14 required core ob-
jectives (eg, maintaining up-to-date medication lists for patients) and
5 menu objectives selected from a set of 10 options (eg, providing pa-
tient-specific educational materials).20 Notably, MU demonstration as
of December 2012 is a different measure than MU attestation status.
According to CMS requirements, in the first year of Stage 1, Medicare-
eligible providers had to demonstrate these objectives for a period of
at least 90 days during the calendar year in order to “attest” for MU
and receive the incentive payments. In this same period, Medicaid-
eligible providers only needed to adopt EHR technology certified for
the MU program in order to “attest” for incentive payments; demon-
stration of the core and menu objectives were required in subsequent
years. However, within UNC HCS, all clinics operated under the same
policies regarding how incentive payments were distributed. These in-
ternal policies required both Medicare- and Medicaid-eligible providers
to demonstrate MU in order to receive incentive payments.
Dichotomous (yes/no) measures of our independent variables (ie, QI
team leading MU implementation, EHR super-user, and nurse cham-
pion) were obtained via the survey described above. Regarding QI
teams, we asked 2 questions: whether there is a QI team in the clinic,
and, if so, whether the QI team “was responsible for leading MU imple-
mentation in the practice site.” We expected that the QI team’s associ-
ation with MU success would be present when the team was directly
involved with MU implementation. The survey did not capture informa-
tion about the roles on the QI team in each clinic. Regarding cham-
pions, we asked separate questions about the presence of a physician
champion and nursing champion. Because 35 of the 37 clinics (95%)
reported having a physician champion, we excluded that variable from
the model. The survey did not capture information about activities the
champion performed to promote MU. We defined “super-user” in the
survey as “a person who uses [the EHR] to its fullest capacity” and in-
dicated that this person could be either an MD or other health care pro-
fessional. Notably, each clinic had access to the same types of MU
support from UNC HCS (eg, training, process improvement coaching)
and contributed financially to cover the costs of this support.
As control variables, we included (1) specialty, defined as either pri-
mary care or specialist, and (2) whether all clinical information was ac-
cessible in the EHR or some clinical information was accessible only via
another system. Specialty accounts for the possibility that MU Stage 1 is
more primary care–centric and therefore more easily attainable by pro-
viders in primary care settings. Accessibility of all clinical information
through the EHR accounts for the possibility that demonstrating MU
Stage 1 is more difficult for those who have to integrate multiple systems
(not just the EHR) into their workflow. Notably, each clinic was using the
same homegrown EHR, which had been implemented several years prior
to the MU program and was then certified for MU. Presumably, clinics us-
ing multiple systems were doing so because the EHR could not capture
and provide access to all necessary data in an efficient way.
Data Analysis
Outcome data (number of providers demonstrating MU Stage 1 objec-
tives out of the total number of eligible providers) were only available
aggregated at the clinic level. Furthermore, survey responses were at
the clinic level. We analyzed our data using generalized estimating
equation methods, with an independence working correlation matrix to
account for clustering of outcomes within clinics and to appropriately
weight the contribution from each clinic according to clinic size.21 We
first assessed associations between demonstration of MU Stage 1 and
the presence of our 4 independent variables by applying separate lo-
gistic regression models for each variable of interest (analogous to
conducting separate chi-square tests for each variable, but appropri-
ately adjusted for clustering). We then fit a full model that simulta-
neously included all 4 variables of interest plus the 2 control variables.
We considered P< .05 to indicate statistically significant associations,
with no adjustments for multiple comparisons. We also explored the
potential for nonadditive associations between combinations of our
variables of interest and demonstration of MU by testing all 2-way in-
teractions. We did this by adding 1 interaction at a time to the full
model and testing the interaction term at the 0.1 level, to allow for re-
duced sensitivity for detecting interactions.
After performing the analyses for all MU eligible providers (ie, both
Medicaid and Medicare), we repeated the process using only
Medicare-eligible providers. We did so because, although UNC HCS
used the same MU demonstration criteria for all eligible providers
when allocating incentive payments, the CMS-defined MU objectives
are different for Medicaid and Medicare providers in year 1 of Stage 1.
If some clinics with Medicaid-eligible providers decided to follow the
CMS-defined timeline rather than the UNC HCS timeline, such clinics
may not have developed their MU implementation strategies (eg, QI
team leading MU implementation) and formed their MU teams (eg,
champions and super-users) according to the same schedule as those
with Medicare-eligible providers. Therefore, our Medicare-only analy-
sis would help detect whether relationships between the variables of
interest and MU Stage 1 demonstration were due to the difference in
the CMS-defined schedule for Medicare and Medicaid providers.
This study was reviewed by the UNC Office of Human Research
Ethics (11-1032).
RESULTS
Of all eligible providers included in this study, 88.8% were demon-
strating MU as of December 2012. Notably, only 1 of our independent
Table 1: Characteristics of practice settings in the study sample
Clinic Characteristics Number
of
Clinics
Number
of
Eligible
Providers
(%)Eligible
Providers
Demonstrating
MU
Total 37 596 88.8
Practice type
Primary care 4 124 96.0
Specialty 33 472 86.8
Practice size
<5 eligible providers 4 12 66.7
5–20 eligible providers 23 217 92.2
>20 eligible providers 10 367 87.5
Incentive programs within the clinic
Medicaid only 4 20 90.0
Medicare only 7 41 97.6
Both Medicaid and
Medicare
26 535 88.0
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variables had a statistically significant association with MU Stage 1
demonstration: having a QI team that leads MU implementation (odds
ratio, OR¼ 3.57, 95% CI, 1.83-6.96, P< 0.001, Table 2). One of our
control variables, whether necessary clinical information is maintained
outside of the EHR in other information systems, also was significant
(OR¼ 0. 41, 95% CI, 0.22-0.79, P¼ .008). Some examples of infor-
mation maintained outside the EHR included disease registries, clinical
trials, and radiation therapy. None of the 2-way interaction terms was
significant at the 0.1 level. Analyses of only the Medicare-eligible pro-
viders yielded similar statistically significant results: QI team leading
MU implementation (OR¼ 2.97, 95% CI, 1.34-6.58, P¼ .008) and
maintaining clinical information outside of the EHR (OR¼ 0.39, 95%
CI, 0.17-0.89, P¼ .025) (results not shown).
DISCUSSION
Our findings indicate that having a QI team that leads MU implementa-
tion is significantly associated with MU Stage 1 demonstration.
However, having neither a nurse MU champion nor an EHR super-user
was significantly associated with MU demonstration. These findings
suggest that linking MU implementation to QI efforts within the clinic,
by having the QI team lead the MU implementation, could lead to more
successful MU demonstration. QI teams provide leadership for QI ac-
tivities in the clinic by establishing QI priorities and expectations (eg,
targets, timelines). Therefore, aligning internal QI priorities with MU re-
quirements could promote positive staff perceptions about the value
and feasibility of MU and ultimately alleviate staff resistance to
change, which is particularly important in small ambulatory prac-
tices.22 The composition of clinic QI teams in this study may have var-
ied in terms of size and roles represented; however, each had access
to coaches, trainers, and analytics experts at the system level (UNC
HCS). The best practices for operating such a model, and the cost of
doing so, are not well studied and require future research.
The fact that having neither a nurse MU champion nor an EHR su-
per-user was associated with successful MU Stage 1 demonstration
runs contrary to the literature,23–25 although this literature is still
evolving. One possible explanation is that some clinics are appointing
champions/super-users without providing the support needed to per-
form the role effectively.26 Another possibility is that the individuals in
the champion/super-user roles may not know how best to perform
their role (eg, champions facilitating communication between organi-
zational units; super-users training front-line users and troubleshoot-
ing problems).27 Future research is needed to guide decisions about
who should be an MU champion/super-user, what these individuals
should do to promote MU success in their clinics, and how clinic lead-
ership can best support their efforts.26
Maintaining some clinical information outside of the EHR, a control
variable in our model, was significantly and negatively related to MU
Stage 1 demonstration. This finding suggests that providers in clinics
that maintain multiple systems for accessing clinical information may
have more difficulty integrating MU within their workflow. Integrating
information from disparate systems into workflow28 and redesigning
workflows to account for new information systems and drive QI29,30
have long been recognized as challenges. The significant association
between QI teams leading MU implementation and providers success-
fully demonstrating MU suggests a key strategy for ambulatory prac-
tices working toward challenging Stage 2 and Stage 3 MU objectives,
as well as impending changes resulting from the Medicare Access
and CHIP Reauthorization Act of 2015 (MACRA). Although details re-
garding MACRA and its relationship to MU are currently unclear, the
movement toward value-based care suggests a tighter relationship
between QI and EHR usage for determining future Medicare pay-
ments.31 Placing governance of EHR modifications under the auspices
of the clinic’s QI structure could facilitate efficient integration of QI pri-
orities, information systems, and workflow redesign.
This study has some limitations. First, there may be practice-level
factors (eg, leadership, culture) and provider-level characteristics (eg,
age) that influence providers’ MU Stage 1 demonstration, which were not
measured in this study. However, our analysis accounted for clustering of
providers within clinics to account for such unmeasured factors to some
extent. Also, because responses to some key survey items (eg, having a
physician champion) varied little in our data, we were unable to estimate
potentially important associations. Finally, our study did not capture more
detailed data about the champions/super-users, such as their level of ex-
perience with EHRs or peer perceptions about their performance as a
champion/super-user. Therefore, it is possible that variation in the effec-
tiveness of champions/super-users between the clinic settings contrib-
uted to a nonsignificant relationship with MU Stage 1 demonstration.
CONCLUSIONS
Our study supports the approach of aligning MU with QI efforts in the
clinical setting by having the QI team lead MU implementation. Future
research is needed to determine whether variations in the characteris-
tics and performance of champions/super-users reveals that they are
indeed an ingredient for success in some settings but not in others.
Identifying such key ingredients for success is critically important as
clinics face increasingly rigorous MU requirements in Stages 2 and 3
of the program.
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